Assistant Professor Peter Jirak
Salzburg university hospital, Salzburg (Austria)
Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis
Event: ESC Congress 2022
Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care
Session: Acute cardiac care and COVID
Dexamethasone treatment attenuates pulmonary embolism rates in severe COVID-19 disease
Event: Heart Failure 2022
Topic: Clinical
Session: Focus on the right side
C - reactive protein is a promising indicator of ventricular arrhythmias in pacemaker patients
Event: ESC Acute CardioVascular Care 2022
Topic: Clinical
Session: e-Posters session
Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: Comparison to other types of severe pneumonia
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Arrhythmias e-posters
Changes in micro-RNA secretion patterns following an anti-CD3 and ATG treatment regulate expression of adherens junctions in PBMCs
Event: Heart Failure 2021
Topic: Diabetes and the Heart
Session: ePoster session
Analysis of novel cardiac markers sST2 and IL-33 in chronic heart failure with reduced ejection fraction
Event: ESC Congress 2019
Topic: Biomarkers
Session: Molecular mechanisms of cardiovascular inflammation
Differences in the expression of the novel cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in HFpEF, ICM and DCM patients
Event: Heart Failure 2019
Topic: Biomarkers
Session: Chronic Heart Failure – Diagnostic Methods
A comparative analysis of novel biomarkers in sepsis and cardiovascular disease
Event: Acute Cardiovascular Care 2019
Topic: Biomarkers
Session: Moderated Poster 7: Acute Coronary Syndromes II
A comparative analysis of the novel cardiac biomarkers sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A in heart failure, STEMI and NSTEMI patients
Event: ESC Congress 2018
Topic: Biomarkers
Session: Chronic heart failure – Diagnostic methods
A comparative analysis of novel cardiac biomarkers (sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A) in patients with heart failure, STEMI and controls without cardiovascular disease
Event: Heart Failure 2018
Topic: Biomarkers
Session: Chronic Heart Failure – Diagnostic Methods
